http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-200600049-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2006-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bda2b9e490f5745478d832dee5996c4 |
| publicationDate | 2006-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GT-200600049-A |
| titleOfInvention | VALSARTAN CA / MG SALT COMBINATION WITH AN ANTIDIABETIC AGENT |
| abstract | THE INVENTION IS RELATED TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES A CALCIUM OR MAGNESIUM SALT OF AN ATTAGONIST OF THE AT1 RECEIVER: (S) -N- (CAROXI-2-METIL-PROP-1-IL) -N-PENTANOIL-N- [2 '- (1H-TETRAZO-5-IL) -BIFENIL-4-IL-METIL] -AMINA (VALSARTAN) AND AT LEAST AN ANTIDIABETIC COMPOUND, PREFERIBLY SELECTED FROM THE CONSISTENT GROUP AN INHIBITOR OF THE DIPEPTIDIL PEPTIDAS IV (IV) , OF THE MODULATORS IN THE INSULIN SIGNALING PATTERNS, SIMILAR TO PROPHIINE INHIBITING TYPHOSINE FORSPHATASES (PTPASES), THE MIMETIC COMPOUNDS OF NON-SMALL MOLECULA GF-FROSPHATAMETHYMPHATIN-GATE-FRUIT-FRUITS-GYM , THE COMPOUNDS THAT INFLUENCE THE PRODUCTION OF UNREGULATED HEPATIC GLUCOSE, AS INHIBITORS OF 6-PHOSPHATES (G6PASE), INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (F-1,6-BPASE), INHIBITORS OF PHOSPHORES GLICÓGENO (GP), THE GLUCAGON RECEIVER ANTAGONISTS AND THE CARBOXIKINASA F ALELOS INHIBITORS F CITOSOLIC OSFOENOLPIRUVATO (PEPCK), AND INHIBITORS OF KINASA PYRUVATO DEHYDROGENASE (PDHK), INSULIN SENSITIVITY INTENSIFIERS, INSULIN SCRETION INTENSIFYERS, ALFA-GLASS ALIDA GISTORS -2-ADRENÉRGICOS. T2006 |
| priorityDate | 2005-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.